VIVOZON PHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss
The total revenue of 082800 for the last quarter is 22.92 B KRW, and it's 24.89% higher compared to the previous quarter. The net income of Q4 23 is -1.42 B KRW.